期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

微淋巴管密度与乳腺浸润性导管癌进展的关系 被引量：1

Relationship between Lymphatic Microvessel Density and Progression of Breast Invasive Ductual Carcinoma
下载PDF
导出
摘要 目的探讨微淋巴管密度与乳腺浸润性导管癌进展的关系。方法对咸宁学院附属第一医院病理科2007年5月至2009年9月存档的73例乳腺IDC组织采用鼠抗人D2-40、VEGFR-3单克隆标记,免疫组化S-P二步法在光镜下观察LMVD。结果 73例D2-40、VEGFR-3标记乳腺IDC组织LMVD明显高于乳腺纤维瘤组织LMVD,两者差异具有统计学意义(P<0.01);不同分期的乳腺IDC组织LMVD差异显著,具有统计学意义(P<0.05)。结论乳腺IDC中存在微淋巴管的生成,与其发展关系密切,LMVD可作为预测乳腺IDC转移和预后的重要依据。 Objective To investigate the relationship between Lymphatic Microvessel Density and progression of Breast Invasive Ductual Carcinoma.Methods The data of 73 cases with breast invasive ductual carcinoma were collected.Monocolonal antibody D2-40 and VEGFR-3 were used to mark endotheliocyte of lymphatic vessels by two-step immunohistochemical staining.Lymphatic microvessels density was observed and counted under microscope.Results LMVD marked by D2-4 and VEGFR-3 in breast invasive ductual carcinoma was significantly higher than that in breast fibroadenoma（P0.01）.LMVD in different pTNM stage was significantly different（P0.05）.Conclusion Lymphatic microvessels can be found in breast invasive ductual carcinoma,which is closely related with the development of breast invasive ductual carcinoma.Conclusion LMVD might be served as a important basis to evaluate the prognosis of patients with breast invasive ductual carcinoma.
作者 刘世杰 邹小平 赵红刚 刁路明
机构地区 武汉大学基础医学院 咸宁学院附属第一医院病理科 咸宁学院病理学教研室
出处 《咸宁学院学报（医学版）》 2010年第5期382-384,共3页 Journal of Xianning Univarsity(medical Sciences)
关键词 乳腺浸润性导管癌 微淋巴管 微淋巴管密度 Breast invasive ductual carcinoma Lymphatic microvessel Lymphatic microvessel density
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献3

  • 1Weidenr N.Tumor angiogenesis:review of current applications in tumor prognostiation[J].Semin Diagn Pathol,1993,10(4):302.
  • 2陈茂根,陈维荣,蔡高阳,庄潮平,李廷汉,廖梓群.淋巴管内皮透明质酸受体-1在直肠癌中的表达及其意义[J].中国普通外科杂志,2007,16(9):906-909. 被引量：5
  • 3Kahn HJ,Marks A.A new monoclonal antibody,D2-40,for detection of lymphatic invasion in primary tumors[J].Lab Invest,2002,82 (9):1255.

二级参考文献10

  • 1Williams CS,Leek RD,Robson AM,et al.Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer[J].J Pathol,2003,200(2):195-206.
  • 2Koukourakis MI,Giatromanolaki A,Sivridis E,et al.LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer[J].J Clin Pathol,2005,58(2):202 -206.
  • 3Stacker SA,Achen MG,Jussila L,et al.Lymphangiogenesis and cancer metastasis[J].Nat Rev Cancer,2002,2(8):573 -583.
  • 4He Y,Karpanen T,Alitalo K.Role of lymphangiogenic factors in tumor metastasis[J].Biochim Biophys Acta,2004,1645(1):3-12.
  • 5Picker LJ,Nakache M,Butcher EC.Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types[J].J Cell Biol,1989,109(2):927 -937.
  • 6Bono P,Wasenius VM,Heikkila,P,et al.High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer[J].Clin Cancer Res,2004,10(21):7144 -7149.
  • 7Jackson DG,Prevo R,Clasper S,et al.LYVE-1,the lymphatic system and tumor lymphangiogenesis[J].TRENDS Immunol,2001,22(6):317-321.
  • 8Williams CS,Leek RD,Robson AM,et al.Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer[J].J Pathol,2003,200(2):195 -206.
  • 9Trojan L,Michel MS,Rensch F,et al.Lymph and blood vessel architecture in benign and malignant prostatic tissue:lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1)[J].J Urol,2004,172(1):103-107.
  • 10Giatromanolaki A,Koukourakis MI,Sivridis E,et al.Invading edge vs.inner' (edvin) patterns of vascularization:an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer[J].J Pathol,2000,192(2):140-149.

共引文献4

同被引文献19

  • 1Stacker SA,Caesar C,Baldwin ME,et al. VEGF - D promotes the metastatic spread of tumor ceils via the lymphatics [ J ]. Nat M ed,2001,7 (2) :186.
  • 2Oichiro 0, Mitsyhiko 0, Kunio A, et al. Expression of Hypoxia - inducible factor (HIF - 1 ct) , VEGF - C and VEGF - D in non - invasive and invasive breast ductal carcinomas [ J]. Anticcancer research, 2005,4 (25) :3003 - 3010.
  • 3Al- Mowallad A, Kirwan C, Byrne G, et al. Vascular endothelial growth factor - C in patients with breast cancer[ J]. In Vivo, 2007,21 (3) :549 -551.
  • 4Gisterek I, Matkowski R, Kozlak J, et al. Evaluation of prognostic value of VEGF -C and VEGF -D in breast cancer:lO years follow - up analysis[J]. Anticancer Res,2007,27(4C) :2797 -2802.
  • 5Cunnick GH,Jiang WG, Gomez KF,et al. Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model[ J]. Bio-ehem Biophys Res Commun, 2001,288(4) : 1043 -1046.
  • 6Bono P,Wasenius VM, Heikkila P,et al. High LYVE - 1 - positive lymphatic vessel numbers are associated with poor outcome in breast cancer[J]. ClinCancerRes,2004 ,10(21):7144-7149.
  • 7Hong YK, Harvey N. Proxl is a master control gene in the program specifying lymphatic endothelial cell fate [ J ], Dev Dyn,2002, 225 : 351 - 357.
  • 8Agarwal B,Saxena R, Morimiya A, et al. Lymphangiogenesls does not occur in breast cancer[ J]. Am J Surg Pathol,2005,29: 1449 -1455.
  • 9Schoppmann SF, Birner P, Studer P, et al. Lymphatic microvessel density and lymphovascular invasion assessed by antipodoplanin immunostaining in human breast cancer[ J ]. Anticancer Res,2001,21 (dA) : 2351 - 2355.
  • 10Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox 1 in the induction of the lymphatic endothelial cell phenotype [ J ]. EMBOJ, 2002,21 (7) :1505 - 1513.

引证文献1

咸宁学院学报（医学版）
2010年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部